Investing Profile

Carlos Solórzano

VCInvestor

Senior Principal at Section 32

s32.com/team/carlos-solorzanoSan Francisco Bay Area

Your Intro Paths to Carlos Solórzano

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Networks Carlos is a member of

Deutsche Bank Network

51 CONNECTIONS

Find Carlos Solórzano on

cb

Current Investing Position

Section 32 Principal

Previous Investment Position

Pivotal bioVenture Partners Sr. Associate

Investment Range

$10K - $50K

Sweet Spot

$25K

Current Fund Size

$740M

Carlos Solórzano is on these Sector & Stage Rankings

Therapeutics (Seed)Digital Health (Seed)BioTech (Seed)Health & Hospital Services (Seed)Health IT (Seed)Therapeutics (Series A)Digital Health (Series A)BioTech (Series A)Health & Hospital Services (Series A)Health IT (Series A)Therapeutics (Series B)Digital Health (Series B)Health IT (Series B)BioTech (Series B)Health & Hospital Services (Series B)San Francisco Bay Area

Carlos Solórzano's Experience

Sr. Principal Section 322022 - Present

Sr. Associate Pivotal Life Sciences2019 - 2022

Sr. Associate Pivotal bioVenture Partners2019 - 2022

Assoc Director, Corporate Strategy Ultragenyx Pharmaceutical Inc.2018 - 2019

Equity Research Associate - Biotechnology Deutsche Bank2016 - 2018

Equity Research Associate - Biotechnology Oppenheimer & Co. Inc.2015 - 2016

NIH Postdoctoral Fellow University of California, San Francisco2010 - 2015

President - Bay Area Chapter Oxbridge Biotech Roundtable2014 - 2014

Carlos Solórzano's Education

Keck Graduate Institute Intensive Summer Business Course

University of California, Irvine Ph.D. Pharmacology and Toxicology

California State Polytechnic University-Pomona B.Sc. Chemical Engineering

Investors who invest with Carlos Solórzano